Academic & Industry Advisors
Special Advisor for Technology Development at Dana-Farber
Former Director of Dana-Farber Translational Research Laboratory
Chief Medical Officer, Alnylam Pharmaceuticals
Investment Director, abrdn
Former Vice President of Research at Tekla Capital Management
Vice President, Head of Business Development and External Innovation, CANbridge Pharmaceuticals Inc.
Principal, Binney Street Capital
Co-Founder, NextRNA Therapeutics
Co-Founder, SAB Member, SanaRx Biotherapeutics
Student Leadership
PhD Candidate, Biological and Biomedical Sciences, Harvard University
PhD Candidate, Biological Sciences in Public Health, Harvard T.H. Chan School of Public Health
Research Scientist, Brigham and Women’s Hospital
Past Student Leadership
Associate Director (2022-2024)
Research Fellow, Neurology, Massachusetts General Hospital and Harvard Medical School
Director (2022-2023)
PhD Candidate, Biological and Biomedical Sciences, Harvard University
Associate Director (2022-2023)
PhD Candidate, Biological and Biomedical Sciences, Harvard University
Associate Director (2019-2021)
Master of Bioethics candidate, Harvard Medical School; Chief Product Officer, FOXO
Director (2023-2024)
PhD Candidate, Biological and Biomedical Sciences, Harvard University
Associate Director (2023-2024)
Research Fellow, Cancer Genetics, Dana-Farber Cancer Institute and Harvard Medical School
